Wiley Bros.-aintree Capital »

Heron Therapeutics shares owned by Wiley Bros.-aintree Capital

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Wiley Bros.-aintree Capital from 13F filings

Historical chart of Wiley Bros.-aintree Capital investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Wiley Bros.-aintree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Wiley Bros.-aintree Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $18k 23k 0.80

More positions owned by Wiley Bros.-aintree Capital

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Johnson & Johnson (JNJ)

View all positions for Wiley Bros.-aintree Capital

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
BlackRock
OrbiMed Advisors
Velan Capital Investment Management
Vanguard Capital Management
Millennium Management
Tejara Capital
Tang Capital Management
Palisade Capital Management
Congress Park Capital
Geode Capital Management
State Street Corporation
JW Asset Management
Pale Fire Capital SE

View all funds holding Heron Therapeutics